Cedar Brook Financial Partners’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,756
Closed -$849K 281
2024
Q1
$849K Sell
6,756
-46
-0.7% -$5.26K 0.17% 142
2023
Q4
$713K Buy
6,802
+2,247
+49% +$245K 0.16% 146
2023
Q3
$482K Buy
4,555
+43
+1% +$4.98K 0.13% 179
2023
Q2
$537K Sell
4,512
-21
-0.5% -$2.17K 0.13% 167
2023
Q1
$421K Buy
4,533
+52
+1% +$4.56K 0.11% 203
2022
Q4
$366K Sell
4,481
-347
-7% -$26.4K 0.1% 223
2022
Q3
$295K Buy
+4,828
New +$353K 0.09% 246
2022
Q2
Sell
-2,847
Closed -$236K 380
2022
Q1
$236K Sell
2,847
-195
-6% -$15.8K 0.06% 323
2021
Q4
$265K Buy
3,042
+524
+21% +$49.2K 0.07% 305
2021
Q3
$219K Buy
+2,518
New +$222K 0.07% 312

Other funds holding ORCL

Cedar Brook Financial Partners's ORCL Position: Q2 2024 in Review

Cedar Brook Financial Partners sold out of Oracle (ORCL) in Q2 2024, closing a stake of 6,756 shares — an estimated $849K sold.

Cedar Brook Financial Partners first reported a position in ORCL in Q3 2021 and held it in 10 quarters. The position peaked at $849K in Q1 2024. 2,915 funds tracked by Wall St. Rank hold ORCL as of Q2 2024.

  • Cedar Brook Financial Partners reported no remaining Oracle position as of Q2 2024 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 6,756 Oracle shares in Q2 2024, an estimated $849K.
  • Cedar Brook Financial Partners first reported a position in Oracle in Q3 2021 and held it in 10 quarters.
  • Cedar Brook Financial Partners's Oracle position peaked at $849K in Q1 2024.
  • 2,915 funds tracked by Wall St. Rank held Oracle as of Q2 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.